In Vitro Evaluation of Phospholipase, Proteinase, and Esterase Activities of Candida parapsilosis and Candida metapsilosis

Mycopathologia

Volumn 172, Issue 6, 2011, Pages 429-438

  Ge, Yi Ping ^a   Lu, Gui Xia ^a   Shen, Yong Nian ^a   da Liu, Wei ^a  

^a INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Candida metapsilosis; Candida parapsilosis; Esterase; Identification; Phospholipase; Proteinase

Indexed keywords

ESTERASE; FUNGAL DNA; FUNGAL PROTEIN; PEPTIDE HYDROLASE; PHOSPHOLIPASE;

ARTICLE; CANDIDA; CANDIDIASIS; CLASSIFICATION; DNA FINGERPRINTING; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SECRETION;

CANDIDA; CANDIDIASIS; DNA FINGERPRINTING; DNA, FUNGAL; ESTERASES; FUNGAL PROTEINS; HUMANS; MOLECULAR TYPING; MYCOLOGICAL TYPING TECHNIQUES; PEPTIDE HYDROLASES; PHOSPHOLIPASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

CANDIDA; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS;

EID: 80855138726     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9440-8     Document Type: Article

References (38)

1. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol. 2001; 39: 3254-9.
2. Almirante B, Rodriguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, Alonso-Tarres C, Rodriguez-Tudela JL, Pahissa A. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006; 44: 1681-5.
3. Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY antimicrobial surveillance program (2003). J Clin Microbiol. 2006; 44: 1782-7.
4. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J, For the Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006; 44: 2816-23.
5. Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008; 21: 601-25.
6. Lin D, Wu LC, Rinaldi MG, Lehmann PF. Three distinct genotypes within Candida parapsilosis from clinical sources. J Clin Microbiol. 1995; 33: 1815-21.
7. Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005; 43: 284-92.
8. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol. 2008; 46: 2659-64.
9. Gomez-Lopez A, Alastruey-Izquierdo A, Rodriguez D, Almirante B, Pahissa A, Rodriguez-Tudela JL, Cuenca-Estrella M, Barcelona Candidemia Project Study Group. Prevalence and susceptibility profile of Candida orthopsilosis and Candida metapsilosis: results from population-based surveillance of candidemia in Spain. Antimicro Agents Chemother. 2008; 52: 1506-9.
10. Tay ST, Na SL, Chong L. Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with blood stream infections. J Med Microbiol. 2009; 58: 185-91.
11. Asadzadeh M, Ahmad S, Al-Sweih N, Khan ZU. Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. J Med Microbiol. 2009; 58: 745-52.
12. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution and antifungal susceptibility profile of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in a tertiary care hospital. J Clin Microbiol. 2009; 47: 2392-7.
13. Goncalves SS, Amorim CS, Nucci M, Padovan ACB, Briones MRS, Melo ASA, Colombo AL. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin Microbiol Infect. 2010; 16: 885-7.
14. Mirhendi H, Brita B, Schonheyder HC, Christensen JJ, Fuursted K, et al. Molecular screening for Candida orthopsilosis and Candida metapsilosis among Danish Candida parapsilosis group blood culture isolates: proposal for a new RFLP profile for differentiation. J Med Microbiol. 2010; 59: 414-20.
15. Chen YC, Lin YH, Chen KW, Li J, Teng HJ, Li SY. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in Taiwan. Diag Microbiol Infec. 2010; 68: 284-92.
16. De Toro M, Torres MJ, Maite R, Aznar J. Characterization of Candida parapsilosis complex isolates. Clin Microbiol Infect. 2011; 17: 418-24.
17. Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005; 48: 365-77.
18. Slifkin M. Tween 80 opacity test responses of various Candida species. J Clin Microbiol. 2000; 38: 4626-8.
19. Aktas E, Yigit N, Ayyildiz A. Esterase activity in various Candida species. J Int Med Res. 2002; 30: 322-4.
20. Kumar CP, Menon T, Sundararajan T, et al. Esterase activity of Candida species isolated from immunocompromised hosts. Rev Iberoam Micol. 2006; 23: 101-3.
21. Shimizu MT, Almeida NQ, Fantinato V, Unterkircher CS. Studies on hyaluronidase, chondroitin sulphatase, proteinase and phospholipase secreted by Candida species. Mycoses. 1996; 39: 161-7.
22. De Bernardis F, Mondello F, San Millan R, Ponton J, Cassone A. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol. 1999; 37: 3481-6.
23. Fernanado PH, Panagoda GJ, Samaranayake LP. The relationship between the acid and alkaline phosphatase activity and the adherence of clinical isolates of Candida parapsilosis to human buccal epithelial cells. APMIS. 1999; 107: 1034-42.
24. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev. 2000; 13: 122-43.
25. Kantarcioglu AS, Yucel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses. 2002; 45: 160-5.
26. Dagdeviren M, Cerikcioglu N, Karavus M. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses. 2005; 48: 321-6.
27. Da Silva EH, Ruiz Lda S, Matsumoto FE, Auler ME, Giudice MC, Moreira D, Szeszs W, Paula CR. Candiduria in a public hospital of Sao Paulo (1999-2004): characteristics of the yeast isolates. Rev Inst Med Trop Sao Paulo. 2007; 49: 349-53.
28. Gokce G, Cerikcioglu N, Yagci A. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia. 2007; 164: 265-9.
29. Tavanti A, Hensgens LAM, Mogavero S, Majoros L, Senesi S, Campa M. Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites. BMC Microbiol. 2010; 10: 203.
30. Franca EJG, Furlaneto-Maia L, Quesada RMB, Favero D, Oliveira MT, Furlaneto MC. Haemolytic and proteinase activities in clinical isolates of Candidaparapsilosis and Candida tropicalis with reference to the isolation anatomic site. Mycoses. 2010 Jan 13. [Epub ahead of print].
31. Pereira CA, Da Costa ACBP, Machado AKS, Beltrame M Jr, et al. Enzymatic activity, sensitivity to antifungal drugs and Baccharis dracunculifolia essential oil by Candida strains isolated from the oral cavities of breastfeeding infants and in their mothers' mouths and nipples. Mycopathologia. 2011; 171: 103-9.
32. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982; 20: 7-14.
33. Chakrabarti A, Nayak N, Talwar P. In vitro proteinase production by Candida species. Mycopathologia. 1991; 114: 163-8.
34. van Asbeck EC, Clemons KV, Stevens DA. Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility. Critic Rev Microbiol. 2009; 35: 283-309.
35. Gácser A, Schafer W, Nosanchuk JS, Salomon S, Nosanchuk JD. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candidametapsilosis in reconstituted human tissue models. Fungal Genet Biol. 2007; 44: 1336-41.
36. Orsi CF, Colombari B, Blasi E. Candidametapsilosis as the least virulent member of the "C. parapsilosis" complex. Med Mycol. 2010; 48: 1024-33.
37. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM. PLoS Pathog. 2010; 6: e100713.
38. Hensgens LAM, Tavanti A, Mogavero S, Ghelardi E, Senesi S. AFLP genotyping of Candida metapsilosis clinical isolates: Evidence for recombination. Fung Genet Biol. 2009; 46: 750-8.